Oulu University Hospital

Kutatók

• JVJuha P Väyrynen
• TRTero Rautio

Futó vizsgálatok

• Még nem toboroz

  T1 Colorectal Cancer After Local Excision: Decision Between Surgery and Active Surveillance (T1LDA Trial)

  NCT07900620· Tampere University Hospital· Forrás

• Toboroz

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· 2. fázis· Faron Pharmaceuticals Ltd· Forrás

• Még nem toboroz

  Randomized Clinical Trial for Tonsil Surgery in Adults With Obstructive Sleep Apnea and Enlarged Tonsils

  NCT07580170· Turku University Hospital· Forrás

• Még nem toboroz

  Thromboprophylaxis with Apixaban during neoadjuvant therapy for muscle-invasive Bladder cancer

  2024-518861-90-00· 4. fázis· HUS-Yhtymae· Forrás

• Toboroz

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

  NCT06282952· Oulu University Hospital· Forrás

• Toboroz

  ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents

  NCT07416292· Heikki Löppönen· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer

  NCT07331519· Oulu University Hospital· Forrás

• Toboroz

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  2025-520982-39-00· 3. fázis· Universita Degli Studi Di Milano Bicocca· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

  2024-516652-18-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  NCT07028853· 3. fázis· Pfizer· Forrás

• Még nem toboroz

  Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer

  NCT07155629· 3. fázis· Helsinki University Central Hospital· Forrás

• Toboroz

  A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  NCT06952803· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  NCT06911502· 3. fázis· Celgene· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

  NCT06696079· 2/3. fázis· Rahul Raj· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  NCT06966700· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  NCT06340568· 3. fázis· BioNTech SE· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  2023-508196-36-00· 2. fázis· Karolinska University Hospital· Forrás

• Toboroz

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  Strengthening Healthy Emotional Co-regulation of Mothers With PCOS and Obesity and Their Infants

  NCT07129434· Oulu University Hospital· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  NCT06824467· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  NCT06989112· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· 3. fázis· Amgen· Forrás

• Toboroz

  A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

  NCT06615479· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Toboroz

  RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer patients in Finland

  NCT01531621· 4. fázis· HUS-Yhtymae· Forrás

• Toboroz

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease.

  2024-512475-12-01· 4. fázis· HUS-Yhtymae· Forrás

• Toboroz

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  NCT06629779· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  NCT06623422· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  DART (19-14434) Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients

  NCT04392504· 1/2. fázis· Oslo University Hospital Hf· Forrás

• Fut, nem toboroz

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer

  NCT06328361· Tampere University Hospital· Forrás

• Toboroz

  Supporting Lifestyle Changes After Delivery

  NCT06241144· Oulu University Hospital· Forrás

• Toboroz

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· 3. fázis· Pfizer· Forrás

• Toboroz

  CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

  NCT06262438· 2. fázis· Princess Maxima Center for Pediatric Oncology· Forrás

• Fut, nem toboroz

  Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)

  NCT06111586· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

  NCT06077760· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Phase II multicenter clinical trial: Mosunetuzumab for early relapse of follicular lymphoma in the Nordic countries (MERLIN/NLG-FL6/ML43841)

  2022-500100-21-01· 2. fázis· Oslo University Hospital Hf· Forrás

• Fut, nem toboroz

  Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

  NCT07579390· Helsinki University Central Hospital· Forrás

• Toboroz

  CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)

  2023-504999-25-00· 3. fázis· Prinses Maxima Centrum voor Kinderoncologie B.V.· Forrás

• Fut, nem toboroz

  A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

  NCT05889182· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

  NCT05794906· 3. fázis· Bayer· Forrás

• Toboroz

  SACK

  2022-501600-10-00· 3. fázis· Karolinska University Hospital· Forrás

Showing 50 of 94.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok14 toboroz
• Akut limfoid leukémia (ALL)4 toboroz
• Tüdőrák4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Elhízás3 toboroz
• Hasnyálmirigyrák3 toboroz
• Méhtestrák3 toboroz
• Mielóma multiplex3 toboroz
• Pitvarfibrilláció3 toboroz
• Vastagbélrák3 toboroz
• Follikuláris limfóma2 toboroz
• Krónikus vesebetegség2 toboroz
• Petefészekrák2 toboroz
• Stroke (szélütés)2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Hearing loss1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Máj- és epeúti rák1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Neuroblasztóma1 toboroz
• Obstructive sleep apnoea1 toboroz
• Polycystic ovary syndrome1 toboroz
• Prosztatarák1 toboroz
• Szarkóma1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC

  2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)

  2022-501538-44-00· 3. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Pfizer· Forrás

• Lezárult

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· 3. fázis· Amgen· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Fut, nem toboroz

  A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

  NCT05567796· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

  NCT05565378· 2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

  NCT05428969· 1/2. fázis· Faron Pharmaceuticals Ltd· Forrás

• Lezárult

  A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

  NCT05171777· 2. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

  NCT05224141· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)

  NCT04725188· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT03850795· 3. fázis· Hinova Pharmaceuticals USA, Inc.· Forrás

• Fut, nem toboroz

  RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

  NCT04597125· 4. fázis· Bayer· Forrás

• Lezárult

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· 3. fázis· Amgen· Forrás

• Lezárult

  Effects of Efficient Lifestyle Counseling Method on the Risks of Cardiovascular Disease in Health Care Center Patients

  NCT04425304· University of Oulu· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04182204· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  DPDIMP#1-trial: Impact of DPYD gene test on the safety and efficacy of fluoropyrimidine therapy

  2024-518448-20-00· 4. fázis· HUS-Yhtymae· Forrás

• Toboroz

  Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

  NCT03642509· University of Aarhus· Forrás

• Lezárult

  Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

  NCT03142334· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· German CLL Study Group· Forrás

• Lezárult

  Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma

  NCT02807636· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Pfizer· Forrás

• Lezárult

  Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer

  NCT01347697· Umeå University· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Polycystic ovary syndrome16 munka · 1 vizsgálat